Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has issued an update.
Charmacy Pharmaceutical Co., Ltd. has announced a final cash dividend of RMB 0.45 per share for the financial year ending December 31, 2024, with shareholders’ approval obtained on May 22, 2025. The dividend will be paid in Hong Kong dollars at a rate of HKD 0.48895 per share, with a specified exchange rate. The announcement includes details on withholding tax rates applicable to different categories of shareholders, impacting non-resident and resident shareholders differently. This dividend declaration reflects the company’s financial performance and commitment to returning value to its shareholders, potentially influencing investor sentiment and market positioning.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the distribution and retail of pharmaceutical products. The company primarily serves the Chinese market, offering a range of healthcare and medical products.
Average Trading Volume: 2,842
Technical Sentiment Signal: Sell
Current Market Cap: HK$831.6M
For detailed information about 2289 stock, go to TipRanks’ Stock Analysis page.